Loading provider…
Loading provider…
Hematology (Internal Medicine) Physician in Cambridge, MN
NPI: 1265454201Primary Practice Location
CAMBRIDGE MEDICAL CENTER
701 Dellwood St S, Cambridge, MN
Primary Employer
Mayo Clinic - Mayo Building and Gonda Building
mayoclinic.org
HQ Phone
Get MD Wei's Phone Numberphone_androidMobile
Get MD Wei's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMN State Medical License
CA State Medical License
2024 - 2026
MN State Medical License
2006 - 2026

American Board of Internal Medicine
Hematology

American Board of Internal Medicine
Medical Oncology
Mayo Clinic Alix School of Medicine - Rochester
college.mayo.edu
Fellowship • Hematology and Medical Oncology
2007 - 2011
Residency • Internal Medicine
2004 - 2007
Beijing Medical University
Medical School
Until 1994
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 58 | 69 |
| 2 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 24 | 88 |
| 3 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 14 | 36 |
| 4 | 99443Physician telephone patient service, 21-30 minutes of medical discussion | 14 | 14 |
The prognostic significance of del6q23 in chronic lymphocytic leukemia.
Authors: Yucai Wang, Timothy Call, Jose Leis, Eli Muchtar, Curtis Hanson, Sameer Parikh, Paul Hampel
Journal: Am J Hematol
Publication Date: 2021-04-07
TCF7L1 regulates colorectal cancer cell migration by repressing GAS1 expression.
Authors: King, Carli M, Ding, Wei, Eshelman, Melanie A, Yochum, Gregory S
Journal: Sci Rep
Publication Date: 2024-05-30
Differential transcriptomic profiling in ibrutinib-naïve versus ibrutinib-resistant Richter syndrome.
Authors: Yucai Wang, Shulan Tian, Timothy Call, Saad Kenderian, Jose Leis, Sameer Parikh, Hanyin Wang
Publication Date: 2021-11
Lead Sponsor: Mayo Clinic
Intervention / Treatment: PROCEDURE: Bone Marrow Biopsy, DRUG: Venetoclax, PROCEDURE: Biospecimen Collection, DRUG: Acalabrutinib, PROCEDURE: Computed Tomography, BIOLOGICAL: Durvalumab, PROCEDURE: Positron Emission Tomography (PET), PROCEDURE: Bone Marrow Aspiration
Lead Sponsor: Zhejiang DTRM Biopharma
Intervention / Treatment: DRUG: DTRM-555
Lead Sponsor: Zhejiang DTRM Biopharma
Intervention / Treatment: DRUG: DTRM-555, DRUG: DTRMWXHS-12, DRUG: DTRM-505